Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Gastroenterology and Hepatology|June 9, 2011
Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2)Richard H Ho, Brenda F Leake, Brad L Urquhart, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 27, 2008
Efficacy of argon plasma coagulation compared to topical formalin application for chronic radiation proctopathyA A Alfadhli, W Mohammed Alazmi, T Ponich, et al.
Dalton Transactions (Cambridge, England : 2003)|May 8, 2010
Heterolytic splitting of H-X bonds at a cationic (PNP)Pd centerLauren C Gregor, Chung-Hsing Chen, Claudia M Fafard, et al.
Alimentary Pharmacology & Therapeutics|November 30, 2012
Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's diseaseA Wilson, V Patel, N Chande, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|March 8, 2016
Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel DiseaseB Al-Judaibi, U I Schwarz, N Huda, et al.
Clinical and Translational Gastroenterology|April 6, 2021
Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort StudyAze Wilson, Qian Wang, Yun-Hee Choi, et al.
Journal of Clinical Epidemiology|April 30, 2014
Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, CanadaEric I Benchimol, Astrid Guttmann, David R Mack, et al.
Pharmacogenetics and Genomics|April 21, 2026
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel diseaseMohammed Alkhalifa, Gio R Dela Cruz, Terry Ponich, et al.
Clinical and Translational Gastroenterology|January 21, 2026
Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort StudyEryn Rooney, Gio R Dela Cruz, Terry Ponich, et al.
Pageof 5